ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Call Transcript January 30, 2025
ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32.
Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Matt, and I’ll be your operator for today’s call. At this time, all participants are in a listen-only mode. Later we’ll conduct a question-and-answer session. Please note that this conference call is being recorded. I would now like to turn the...
